After today, I have only one more session of therapy for my current bout with depression. I don’t mean to imply that I’m getting chased out the door, or that more therapy won’t be recommended in the future, just that I’ve come to the end of my current program. I…
Read more
Tech company Century Health has entered into a partnership to organize and clean Nira Medical‘s datasets from more than 3,000 people with multiple sclerosis (MS) to help make clinical data more available for researchers to explore insights toward developing new treatments. “We’re thrilled to partner with Nira…
A new website aims to provide support to caregivers of people with multiple sclerosis (MS). The site, MS Care Partner Connection, brings together information on how caregivers can care for themselves while tending to those living with the disease, how to navigate the healthcare system, and how to…
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) has cleared Pheno Therapeutics to initiate a first-in-human Phase 1 clinical trial to test its oral candidate PTD802 in healthy volunteers. The therapy is a selective small molecule antagonist, or inhibitor, of the GPR17 receptor and is designed to restore…
TG Therapeutics is working to develop a subcutaneous, or under-the-skin, version of Briumvi (ublituximab-xiiy), its approved therapy for relapsing forms of multiple sclerosis (MS). The company said it plans to start a pivotal clinical program this year which could support an application seeking approval of the…
Get regular updates to your inbox.
